• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型冠状病毒肺炎及其对消化系统的影响。

COVID-19 and its effects on the digestive system.

机构信息

Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.

Department of Respiratory and Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan 430071, Hubei Province, China.

出版信息

World J Gastroenterol. 2021 Jun 28;27(24):3502-3515. doi: 10.3748/wjg.v27.i24.3502.

DOI:10.3748/wjg.v27.i24.3502
PMID:34239265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8240057/
Abstract

Coronavirus disease 2019 (COVID-19) is caused by infection of the coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with typical respiratory symptoms. SARS-CoV-2 invades not only the respiratory system, but also other organs expressing the cell surface receptor angiotensin converting enzyme 2. In particular, the digestive system is a susceptible target of SARS-CoV-2. Gastrointestinal symptoms of COVID-19 include anorexia, nausea, vomiting, diarrhea, abdominal pain, and liver damage. Patients with digestive damage have a greater chance of progressing to severe or critical illness, a poorer prognosis, and a higher risk of death. This paper aims to summarize the digestive system symptoms of COVID-19 and discuss fecal-oral contagion of SARS-CoV-2. It also describes the characteristics of inflammatory bowel disease patients with SARS-CoV-2 infection and discusses precautions for preventing SARS-CoV-2 infection during gastrointestinal endoscopy procedures. Improved attention to digestive system abnormalities and gastrointestinal symptoms of COVID-19 patients may aid health care providers in the process of clinical diagnosis, treatment, and epidemic prevention and control.

摘要

新型冠状病毒病(COVID-19)是由冠状病毒严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)感染引起的,具有典型的呼吸道症状。SARS-CoV-2 不仅侵袭呼吸系统,还侵袭表达细胞表面受体血管紧张素转换酶 2 的其他器官。特别是,消化系统是 SARS-CoV-2 的易感靶器官。COVID-19 的胃肠道症状包括食欲不振、恶心、呕吐、腹泻、腹痛和肝损伤。有消化损伤的患者进展为重症或危重症的机会更大,预后更差,死亡风险更高。本文旨在总结 COVID-19 的消化系统症状,并讨论 SARS-CoV-2 的粪-口传播。还描述了感染 SARS-CoV-2 的炎症性肠病患者的特征,并讨论了在胃肠内镜检查过程中预防 SARS-CoV-2 感染的注意事项。提高对 COVID-19 患者消化系统异常和胃肠道症状的关注,可能有助于医疗保健提供者进行临床诊断、治疗和疫情防控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b0/8240057/c05dbda03618/WJG-27-3502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b0/8240057/c05dbda03618/WJG-27-3502-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c5b0/8240057/c05dbda03618/WJG-27-3502-g001.jpg

相似文献

1
COVID-19 and its effects on the digestive system.新型冠状病毒肺炎及其对消化系统的影响。
World J Gastroenterol. 2021 Jun 28;27(24):3502-3515. doi: 10.3748/wjg.v27.i24.3502.
2
Gastrointestinal and hepatic diseases during the COVID-19 pandemic: Manifestations, mechanism and management.新型冠状病毒肺炎疫情期间的胃肠道和肝脏疾病:表现、机制与处理。
World J Gastroenterol. 2021 Jul 28;27(28):4504-4535. doi: 10.3748/wjg.v27.i28.4504.
3
COVID-19 induces gastrointestinal symptoms and affects patients' prognosis.新冠病毒可引起胃肠道症状,并影响患者的预后。
J Int Med Res. 2022 Oct;50(10):3000605221129543. doi: 10.1177/03000605221129543.
4
COVID-19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract.COVID-19 大流行:胃肠道的病理生理学和表现。
World J Gastroenterol. 2020 Aug 21;26(31):4579-4588. doi: 10.3748/wjg.v26.i31.4579.
5
Gastrointestinal symptoms in patients with COVID-19: Is there a relationship with mortality and new variations of SARS-CoV-2?COVID-19 患者的胃肠道症状:与死亡率和 SARS-CoV-2 的新变异有关吗?
World J Gastroenterol. 2021 Oct 7;27(37):6345-6347. doi: 10.3748/wjg.v27.i37.6345.
6
Potential effects of SARS-CoV-2 on the gastrointestinal tract and liver.SARS-CoV-2 对胃肠道和肝脏的潜在影响。
Biomed Pharmacother. 2021 Jan;133:111064. doi: 10.1016/j.biopha.2020.111064. Epub 2020 Nov 28.
7
Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.SARS-CoV-2 的胃肠道表现:传播、发病机制、免疫调节、微生物失调和临床意义。
Viruses. 2023 May 24;15(6):1231. doi: 10.3390/v15061231.
8
COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations.COVID-19 肺外疾病——特殊的胃肠道和肝脏注意事项。
Dis Mon. 2020 Sep;66(9):101064. doi: 10.1016/j.disamonth.2020.101064. Epub 2020 Jul 28.
9
Involvement of digestive system in COVID-19: manifestations, pathology, management and challenges.新型冠状病毒肺炎中消化系统的受累情况:表现、病理、管理及挑战
Therap Adv Gastroenterol. 2020 Jun 18;13:1756284820934626. doi: 10.1177/1756284820934626. eCollection 2020.
10
Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians.新冠疫情期间的胃肠道表现及营养治疗:儿科医生实用指南
Einstein (Sao Paulo). 2020;18:eRW5774. doi: 10.31744/einstein_journal/2020rw5774. Epub 2020 Jul 10.

引用本文的文献

1
COVID-19 - multisystem disease.新冠病毒病——多系统疾病。
Rom J Morphol Embryol. 2025 Jan-Mar;66(1):61-67. doi: 10.47162/RJME.66.1.05.
2
Gastroesophageal reflux disease increases predisposition to severe COVID-19: Insights from integrated Mendelian randomization and genetic analysis.胃食管反流病增加了患重症 COVID-19 的易感性:来自整合孟德尔随机化和遗传分析的见解。
Ann Hum Genet. 2025 Jan;89(1):54-65. doi: 10.1111/ahg.12584. Epub 2024 Nov 12.
3
Possible mechanisms of SARS-CoV-2-associated myocardial fibrosis: reflections in the post-pandemic era.

本文引用的文献

1
The green tea catechin epigallocatechin gallate inhibits SARS-CoV-2 infection.绿茶儿茶素表没食子儿茶素没食子酸酯抑制 SARS-CoV-2 感染。
J Gen Virol. 2021 Apr;102(4). doi: 10.1099/jgv.0.001574.
2
A model to predict the risk of mortality in severely ill COVID-19 patients.一种预测重症 COVID-19 患者死亡风险的模型。
Comput Struct Biotechnol J. 2021;19:1694-1700. doi: 10.1016/j.csbj.2021.03.012. Epub 2021 Mar 22.
3
Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19.入院时白蛋白水平较高的 COVID-19 确诊患者预后较好。
新型冠状病毒2型相关心肌纤维化的可能机制:大流行后时代的思考
Front Microbiol. 2024 Oct 8;15:1470953. doi: 10.3389/fmicb.2024.1470953. eCollection 2024.
4
Impact of the COVID-19 pandemic on risk of sarcopenia: From lockdown and infection perspectives: A systematic review and meta-analysis.COVID-19 大流行对肌少症风险的影响:从封锁和感染角度来看:系统评价和荟萃分析。
Medicine (Baltimore). 2024 Aug 9;103(32):e39257. doi: 10.1097/MD.0000000000039257.
5
Investigating the trajectory of post-COVID impairments: a longitudinal study in Sweden.调查新冠后损伤的轨迹:瑞典的一项纵向研究。
Front Psychol. 2024 Jun 10;15:1402750. doi: 10.3389/fpsyg.2024.1402750. eCollection 2024.
6
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?2023 年关于 COVID-19、可能的肝脏途径和酒精滥用,我们了解多少?
Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212.
7
The impact of Sars-Cov-2 infection on the wound healing of cervical treatment in patients with squamous intraepithelial lesions: a retrospective cohort study.严重急性呼吸综合征冠状病毒2(Sars-Cov-2)感染对鳞状上皮内病变患者宫颈治疗伤口愈合的影响:一项回顾性队列研究。
Front Med (Lausanne). 2023 Dec 7;10:1222767. doi: 10.3389/fmed.2023.1222767. eCollection 2023.
8
Differences in door-to-balloon time and outcomes in SARS-CoV-2-positive ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review and meta-analysis.新型冠状病毒阳性 ST 段抬高型心肌梗死患者行直接经皮冠状动脉介入治疗的门球时间和结局差异:系统评价和荟萃分析。
Medicine (Baltimore). 2023 Oct 13;102(41):e35612. doi: 10.1097/MD.0000000000035612.
9
Exploring Key Biomarkers and Common Pathogenesis of Seven Digestive System Cancers and Their Correlation with COVID-19.探索七种消化系统癌症的关键生物标志物、共同发病机制及其与COVID-19的相关性。
Curr Issues Mol Biol. 2023 Jun 30;45(7):5515-5533. doi: 10.3390/cimb45070349.
10
Organokines in COVID-19: A Systematic Review.COVID-19 中的器官激酶:系统评价。
Cells. 2023 May 9;12(10):1349. doi: 10.3390/cells12101349.
PLoS One. 2021 Mar 16;16(3):e0248358. doi: 10.1371/journal.pone.0248358. eCollection 2021.
4
Laboratory Predictors of COVID-19 Mortality: A Retrospective Analysis from Tongji Hospital in Wuhan.实验室预测 COVID-19 死亡率:来自武汉同济医院的回顾性分析。
Mediators Inflamm. 2021 Feb 23;2021:6687412. doi: 10.1155/2021/6687412. eCollection 2021.
5
EGCG, a Green Tea Catechin, as a Potential Therapeutic Agent for Symptomatic and Asymptomatic SARS-CoV-2 Infection.EGCG,一种绿茶儿茶素,作为一种有潜力的治疗药物用于有症状和无症状的 SARS-CoV-2 感染。
Molecules. 2021 Feb 24;26(5):1200. doi: 10.3390/molecules26051200.
6
Hypoalbuminemia on admission in COVID-19 infection: An early predictor of mortality and adverse events. A retrospective observational study.COVID-19 感染入院时的低白蛋白血症:死亡和不良事件的早期预测指标。一项回顾性观察研究。
Med Clin (Barc). 2021 May 7;156(9):428-436. doi: 10.1016/j.medcli.2020.12.018. Epub 2021 Jan 28.
7
Nutritional perspectives for the prevention and mitigation of COVID-19.预防和缓解 COVID-19 的营养角度。
Nutr Rev. 2021 Feb 11;79(3):289-300. doi: 10.1093/nutrit/nuaa063.
8
Case Report: The Coronavirus Disease 2019 (COVID-19) Pneumonia With Multiple Thromboembolism.病例报告:2019冠状病毒病(COVID-19)肺炎合并多发性血栓栓塞
Front Neurol. 2021 Jan 12;11:625272. doi: 10.3389/fneur.2020.625272. eCollection 2020.
9
Cytokine Storm and Mucus Hypersecretion in COVID-19: Review of Mechanisms.新冠病毒肺炎中的细胞因子风暴与黏液高分泌:机制综述
J Inflamm Res. 2021 Jan 22;14:175-189. doi: 10.2147/JIR.S271292. eCollection 2021.
10
Risk of COVID 19 in patients with inflammatory bowel diseases compared to a control population.炎症性肠病患者与对照人群 COVID-19 发病风险比较。
Dig Liver Dis. 2021 Mar;53(3):263-270. doi: 10.1016/j.dld.2020.12.013. Epub 2020 Dec 26.